Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_assertion type Assertion NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_head.
- NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_provenance.
- NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_assertion evidence source_evidence_literature NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_provenance.
- NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_assertion SIO_000772 17609426 NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_provenance.
- NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_assertion wasDerivedFrom lhgdn-20090331 NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_provenance.
- NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_assertion wasGeneratedBy ECO_0000203 NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_provenance.